Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach

Por de Weerdt, Iris, Koopmans, Suzanne M., Kater, Arnon P., van Gelder, Michel
Publicado no Haematologica (2017)

Innate lymphoid cells are expanded and functionally altered in chronic lymphocytic leukemia

Por de Weerdt, Iris, van Hoeven, Vera, Munneke, J. Marius, Endstra, Sanne, Hofland, Tom, Hazenberg, Mette D., Kater, Arnon P.
Publicado no Haematologica (2016)

Ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study

Por Burger, Jan A., Keating, Michael J., Wierda, William G., Hartmann, Elena, Hoellenriegel, Julia, Rosin, Nathalie Y., de Weerdt, Iris, Jeyakumar, Ghayathri, Ferrajoli, Alessandra, Cardenas-Turanzas, Marylou, Lerner, Susan, Jorgensen, Jeffrey L, Nogueras-González, Graciela M., Zacharian, Gracy, Huang, Xuelin, Kantarjian, Hagop, Garg, Naveen, Rosenwald, Andreas, O’Brien, Susan
Publicado em 2014